Member Info for dougerboy

Fair chance Smart - it could be be very special - hope so! Or it could be steady as she goes - probable & fine. Or it could be a damp squib - hope not! We’ll just have to sit our hands a bit longer.

Fair point Surfie. None of us have a crystal ball and stuff can & does happen with risks that sometimes come home to roost. If we were beyond break even - which has been a long time coming - I’d be a tad happier. I’ve not given up yet though on my 20p by (end of) ‘23. Hoping this year’s RNS’s march us towards that.

Hi all, at (slightly nervous!) times like this sometimes we need a reminder of what we actually have (I know I do) to help keep the faith; so here is one: an excerpt from a Nouryon Press Release in 2019 - not that long ago:

“The new range of polymers strengthens Nouryon’s position as a leader in the chelates industry,” Kuijpers said. “Establishing this unique position is of strategic importance and underlines our commitment to sustainable growth.”

Peter Nieuwenhuizen, Chief Technology Officer at Nouryon, added: “We are pleased to complete the first supply agreement under our collaboration with Itaconix around its novel itaconic acid polymer platform. We firmly believe in the power and potential of collaborative innovation. By partnering, we create even greater innovation opportunities to offer to our customers.”

John R. Shaw, CEO of Itaconix, said: “I am excited that our joint work with Nouryon over the last year has created this global opportunity for our polymers.”

Peter Nieuwenhuizen is now our chair.

Im going to go for next Tuesday or Wed for TU with announcement of unaudited final results 2022. The bonus scheme wording does not use the word „audited“

I‘m probably wrong though!

Every single box is ticked for me AJP - apart from one:

The box which says:

Profitable Revenue Growth Curve Back on Track.

C‘mon Itaconix, it‘s no longer if but when.

Maybe we LTH’s should all offer ourselves as free commission only sales champions!

Slainte

Nice one Smart. Let’s hope we get really strong 2022 final results coming out soon. Maybe the sooner the better as far as the EXec team is concerned, as their last chance of a share award from current and expiring share bonus programme is based on average share price (it’s been low!) in 30 days prior to final results announcement, and revenue growth.

Fair point JD. I’m not a fan of nudges & winks. I prefer data. Eg import shipments of raw materials.

I think that’s a lot of tosh AJP. The only thing that really matters is evidence of continued (increasingly profitable) growth along the published - albeit delayed - revenue growth curve. Hopefully confirmed by the company in its next RNS. The share price movement seems to suggest that!

I’d wager Q2 2023 for share consolidation Elsol. We shall see!

That is a good spot Smart and a strapline which says it all in summarising Itaconix‘ Value Proposition.

Merry Christmas! Where will we be this time next year? C‘mon John, light the touchpaper in 2023!

Well done for buying more Smart. Any lower and I might do the same. Interestingly, when sells are made, people often are not so vocal, like one poster - a bit of a tube - over on the ITX ADVFN board who told the world & its granny about his every purchase, but was silent on his sales & then stuck the boot into the company.

Onto more important things: glad to see this major player is also distributing Itaconix product & apologies if the info was already posted somewhere:

https://omyakinetik.com/wp-content/uploads/Neutralize-Natural-Deodorant-Formulation-Card.pdf

I concur JD - Revenues without sufficient margin - long term - is not good at all. Short term, I can accept there may be a case of lowering to get the product in. I looked at Croda & Nouryon GMs a while back and recall they were hi 30‘s/low 40‘s. Good enough for them, good enough for us!

I reckon late January WB. Of key interest to me is if the contingent liability of $1.1M gets paid in full by way of shares per the the management incentive programme, based on 2022 results. I hope it does - it means revenues are growing faster. And hopefully with a better GM.

I agree JD - so it will be interesting to see how quickly the 2022 results are put out.

Hi JD I’m only stating that IF on release of 2022 numbers, a share award based on revenue growth targets being met is due, then the number of shares awarded will be higher if the share price remains low. See RNS from June 20th 2016 for scheme details. AND 2022 numbers will bring to a close this scheme. So last chance for Exec Team to benefit from it.

This is one thing that may impact the EXEC Team Smart:

“Such deferred performance related consideration, if any, shall be satisfied annually in the form of Deferred Consideration Shares issued at a price equivalent to the volume-weighted average closing mid-market share price over the 30 trading days immediately preceding the first day on which the financial results for the prior year with reference to which such deferred performance related consideration will be calculated are publicly released.”

2022 books close in 17 days!

Informative post JD and I concur. A long while back I think I mentioned a number of $8M + for Break Even, and that was based on the previous (& better)GM. So for me the focus must be on PROFITABLE growth. Sales without sufficient margin is not a long term strategy for the company or its customers.

AJP, I have to say, that is a brilliant find. I don’t know what, if anything, may result from it, but our company is on the same platform as BASF and I’m a shareholder in both (with small positions) which means I’m a lookin’ an’ a likin’

Thordon great work. You are a sleuth among sleuths thank you for your research and dedication to a tiny mCap company which has been flying its green credentials FLAG - some might say too feebly - or too tardily- over the past number of years, but we are on the cusp of something special. When I say „we“ credit must go to Yvon Durant - the company scientist, engineer, visionary, and IP/Patent Protector who has delivered a rock solid foundation for us.